Rethinking risk assessment for emerging technology first-in-human trials
Crossref DOI link: https://doi.org/10.1007/s11019-015-9660-7
Published Online: 2015-08-15
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Genske, Anna
Engel-Glatter, Sabrina
Funding for this research was provided by:
Swiss National Science Foundation
Text and Data Mining valid from 2015-08-15